Clinical trials: Drug Infusion (Implantable Pumps)
Refractory Pain
Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED)
Refractory pain is a prevalent condition that negatively affects patients' quality of life. Intrathecal implantable systems have been proposed as a treatment option for refractory pain.
- Trial name
- NCT05970081
- Where
- 9 sites in Spain
- Volunteers
- 504 people
- Sponsor
- Sociedad Espanola del Dolor
Severe Spasticity, Chronic Pain
SynchroMed II Post-Approval Study
This FDA Condition of Approval study will include up to 100 subjects at up to 13 US centers. Subjects are selected from those evaluated and planning to receive a SynchroMed II drug infusion system for treatment of severe…
- Trial name
- NCT00773019
- Testing
- Refills (SynchroMed® II Programmable Drug Infusion Pump)
- Volunteers
- 84 people
- Sponsor
- MedtronicNeuro
Spinal Cord Stimulation, Deep Brain Stimulation
Implantable Systems Performance Registry
The Implantable Systems Performance Registry (ISPR) was developed to evaluate the long-term reliability and performance of market-released Medtronic Neuromodulation infusion and stimulation products.
- Conditions
- Spinal Cord Stimulation, Deep Brain Stimulation, Drug Infusion (Implantable Pumps), Sacral Neuromodulation
- Trial name
- ISPR (NCT00959296)
- Testing
- Various
- Where
- 50 sites in United States, Austria and 5 more
- Volunteers
- 10,981 people
- Sponsor
- MedtronicNeuro